Literature DB >> 24177988

Neural substrates of inhibitory control deficits in 22q11.2 deletion syndrome.

C A Montojo1, M Jalbrzikowski2, E Congdon3, S Domicoli2, C Chow3, C Dawson4, K H Karlsgodt5, R M Bilder1, C E Bearden6.   

Abstract

22q11.2 deletion syndrome (22q11DS) is associated with elevated levels of impulsivity, inattention, and distractibility, which may be related to underlying neurobiological dysfunction due to haploinsufficiency for genes involved in dopaminergic neurotransmission (i.e. catechol-O-methyltransferase). The Stop-signal task has been employed to probe the neural circuitry involved in response inhibition (RI); findings in healthy individuals indicate that a fronto-basal ganglia network underlies successful inhibition of a prepotent motor response. However, little is known about the neurobiological substrates of RI difficulties in 22q11DS. Here, we investigated this using functional magnetic resonance imaging while 45 adult participants (15 22q11DS patients, 30 matched controls) performed the Stop-signal task. Healthy controls showed significantly greater activation than 22q11DS patients within frontal cortical and basal ganglia regions during successful RI, whereas 22q11DS patients did not show increased neural activity relative to controls in any regions. Using the Barratt Impulsivity Scale, we also investigated whether neural dysfunction during RI was associated with cognitive impulsivity in 22q11DS patients. RI-related activity within left middle frontal gyrus and basal ganglia was associated with severity of self-reported cognitive impulsivity. These results suggest reduced engagement of RI-related brain regions in 22q11DS patients, which may be relevant to characteristic behavioral manifestations of the disorder.
© The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  fronto-basal ganglia; impulsivity; response inhibition; velocardiofacial syndrome

Mesh:

Year:  2013        PMID: 24177988      PMCID: PMC4366617          DOI: 10.1093/cercor/bht304

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  63 in total

Review 1.  Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway.

Authors:  Atsushi Nambu; Hironobu Tokuno; Masahiko Takada
Journal:  Neurosci Res       Date:  2002-06       Impact factor: 3.304

2.  fMRI evidence that the neural basis of response inhibition is task-dependent.

Authors:  Stewart H Mostofsky; Joanna G B Schafer; Michael T Abrams; Melissa C Goldberg; Abigail A Flower; Avery Boyce; Susan M Courtney; Vince D Calhoun; Michael A Kraut; Martha B Denckla; James J Pekar
Journal:  Brain Res Cogn Brain Res       Date:  2003-07

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  Modeling group fMRI data.

Authors:  Jeanette A Mumford; Russell A Poldrack
Journal:  Soc Cogn Affect Neurosci       Date:  2007-09       Impact factor: 3.436

5.  A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention.

Authors:  Ana Cubillo; Rozmin Halari; Anna Smith; Eric Taylor; Katya Rubia
Journal:  Cortex       Date:  2011-04-27       Impact factor: 4.027

6.  Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.

Authors:  H M Lachman; B Morrow; R Shprintzen; S Veit; S S Parsia; G Faedda; R Goldberg; R Kucherlapati; D F Papolos
Journal:  Am J Med Genet       Date:  1996-09-20

7.  Object-related activity revealed by functional magnetic resonance imaging in human occipital cortex.

Authors:  R Malach; J B Reppas; R R Benson; K K Kwong; H Jiang; W A Kennedy; P J Ledden; T J Brady; B R Rosen; R B Tootell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

8.  Association of the COMT Met¹⁵⁸ allele with trait impulsivity in healthy young adults.

Authors:  Márcio Gerhardt Soeiro-De-Souza; Matthew S Stanford; Danielle Soares Bio; Rodrigo Machado-Vieira; Ricardo Alberto Moreno
Journal:  Mol Med Rep       Date:  2013-02-21       Impact factor: 2.952

9.  A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome.

Authors:  R J Shprintzen; R B Goldberg; M L Lewin; E J Sidoti; M D Berkman; R V Argamaso; D Young
Journal:  Cleft Palate J       Date:  1978-01

10.  Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory.

Authors:  Roshan Cools; Margaret Sheridan; Emily Jacobs; Mark D'Esposito
Journal:  J Neurosci       Date:  2007-05-16       Impact factor: 6.167

View more
  8 in total

1.  Verbal-spatial IQ discrepancies impact brain activation associated with the resolution of cognitive conflict in children and adolescents.

Authors:  Amy E Margolis; Katie S Davis; Lisa S Pao; Amy Lewis; Xiao Yang; Gregory Tau; Guihu Zhao; Zhishun Wang; Rachel Marsh
Journal:  Dev Sci       Date:  2017-02-15

Review 2.  Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development.

Authors:  Daniel W Meechan; Thomas M Maynard; Eric S Tucker; Alejandra Fernandez; Beverly A Karpinski; Lawrence A Rothblat; Anthony-S LaMantia
Journal:  Prog Neurobiol       Date:  2015-04-09       Impact factor: 11.685

3.  Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts.

Authors:  James J Yi; Ronnie Weinberger; Tyler M Moore; Monica E Calkins; Yael Guri; Donna M McDonald-McGinn; Elaine H Zackai; Beverly S Emanuel; Raquel E Gur; Doron Gothelf; Ruben C Gur
Journal:  Brain Cogn       Date:  2016-05-17       Impact factor: 2.310

4.  MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del.

Authors:  Dejian Zhao; Mingyan Lin; Jian Chen; Erika Pedrosa; Anastasia Hrabovsky; H Matthew Fourcade; Deyou Zheng; Herbert M Lachman
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

5.  A phenome-wide examination of neural and cognitive function.

Authors:  R A Poldrack; E Congdon; W Triplett; K J Gorgolewski; K H Karlsgodt; J A Mumford; F W Sabb; N B Freimer; E D London; T D Cannon; R M Bilder
Journal:  Sci Data       Date:  2016-12-06       Impact factor: 6.444

6.  Altered functional brain dynamics in chromosome 22q11.2 deletion syndrome during facial affect processing.

Authors:  Raquel E Gur; Dani S Bassett; Eli J Cornblath; Arun Mahadevan; Xiaosong He; Kosha Ruparel; David M Lydon-Staley; Tyler M Moore; Ruben C Gur; Elaine H Zackai; Beverly Emanuel; Donna M McDonald-McGinn; Daniel H Wolf; Theodore D Satterthwaite; David R Roalf
Journal:  Mol Psychiatry       Date:  2021-10-22       Impact factor: 13.437

7.  Structural and functional connectivity in the default mode network in 22q11.2 deletion syndrome.

Authors:  Maria Carmela Padula; Marie Schaer; Elisa Scariati; Maude Schneider; Dimitri Van De Ville; Martin Debbané; Stephan Eliez
Journal:  J Neurodev Disord       Date:  2015-08-01       Impact factor: 4.025

8.  Neural mechanisms of response inhibition and impulsivity in 22q11.2 deletion carriers and idiopathic attention deficit hyperactivity disorder.

Authors:  C A Montojo; E Congdon; L Hwang; M Jalbrzikowski; L Kushan; T K Vesagas; R K Jonas; J Ventura; R M Bilder; C E Bearden
Journal:  Neuroimage Clin       Date:  2015-08-20       Impact factor: 4.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.